home / stock / bpts / bpts news

BPTS News and Press, Biophytis SA From 04/08/24

Stock Information
Company Name: Biophytis SA
Stock Symbol: BPTS
Market: NASDAQ
Menu
BPTS BPTS Quote BPTS Short BPTS News BPTS Articles BPTS Message Board
Get BPTS Alerts

News, Short Squeeze, Breakout and More Instantly...
BPTS - Biophytis Announces Its 2023 Financial Results and Provides an Update on Its Business Activities

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / April 8, 2024 / Biophytis SA (Nasdaq CM:BPTS, Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics for age-related diseases, publishes today its financi...
BPTS - Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone)

Promising preclinical results obtained in obesity support the OBA Phase 2 clinical study expected to start mid-2024 PARIS, FRANCE AND CAMBRIDGE, MA / ACCESSWIRE / April 8, 2024 / Biophytis SA (Nasdaq:BPTS)(Euronext Growth Paris: ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotec...

BPTS - Results of the Combined General Meeting on April 2, 2024

All resolutions presented by the Company have been adopted PARIS, FRANCE AND CAMBRIDGE, MA / ACCESSWIRE / April 4, 2024 / Biophytis SA (NASDAQ CM BPTS),(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of ther...

BPTS - Biophytis Presented its Phase 3 Protocol in the Treatment of Sarcopenia

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / March 22, 2024 / Biophytis SA (Nasdaq:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes asso...
BPTS - Biophytis SA receives non compliance notice from Nasdaq

2023-11-17 17:23:20 ET More on Biophytis Biophytis receives notice of delisting from Nasdaq Biophytis and Skyepharma sign partnership agreement for production of Sarconeos For further details see: Biophytis SA receives non compliance notice from Nasdaq

BPTS - Biophytis and Innovation Solutions Pharma Sign a Partnership Agreement to Accelerate Market Access for Sarconeos (BIO101) in Brazil

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / October 30,2023 / Biophytis SA (Nasdaq CM:BPTS)(Euronext Growth Paris:ALBPS), («Biophytis»), a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes associa...

BPTS - Biophytis receives notice of delisting from Nasdaq

2023-10-27 17:24:16 ET More on Biophytis Biophytis and Skyepharma sign partnership agreement for production of Sarconeos Seeking Alpha’s Quant Rating on Biophytis Historical earnings data for Biophytis Financial information for Biophytis For fu...
BPTS - Biophytis Receives Notice of Delisting From Nasdaq and Announces It Will Request a Hearing Before the Nasdaq Hearings Panel

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / October 27, 2023 / Biophytis SA (NASDAQ CM:BPTS, Euronext Growth Paris:ALBPS), ("Biophytis"), a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes associated with ...

BPTS - 24/7 Market News Wrap for 29 Sept 2023

2023-09-29 16:58:27 ET DENVER, Colo., Sept 29, 2023 ( www.247marketnews.com )- It was like this week shot out of a canon. Monday We started the week by covering Biophytis SA (NASDAQ: BPTS) and Skyepharma signing a partnership agreement for the production of regulatory batche...

BPTS - Biophytis reports 1H results

2023-09-28 11:15:39 ET More on Biophytis Biophytis and Skyepharma sign partnership agreement for production of Sarconeos Seeking Alpha’s Quant Rating on Biophytis Historical earnings data for Biophytis Financial information for Biophytis For fu...
Previous 10 Next 10